Novartis

The logo of Swiss drugmaker Novartis is pictured at the French company's headquarters in Rueil-Malmaison near Paris, France, April 22, 2020. REUTERSCharles Platiau
Coronavirus chronicle

Swiss drugmaker Novartis to help make Pfizer-Biontech Covid-19 vaccine

Novartis plans to commence production in the second quarter of 2021

The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020/Reuters
Global Economy

Novartis trims sales outlook after hit from Covid disruptions

The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020/Reuters
Coronavirus chronicle

Novartis to provide 'no profit' Covid-19 drugs to low income countries

Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017/ Reuters
World

Novartis faces key meeting in US bribery scandal after settling corruption case

A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease in Liege, Belgium, June16, 2020/ Reuters
Coronavirus chronicle

Novartis halts malaria drug trial against Covid-19 amid participant shortfall

Novartis donates safety gears to combat coronavirus
Covid-19 in Bangladesh

Novartis donates safety gears to combat coronavirus

FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the French company's headquarters in Rueil-Malmaison near Paris, France, April 22, 2020. REUTERS/Charles Platiau
Coronavirus chronicle

Novartis inks deal to make Mass General Brigham's Covid-19 vaccine candidate

The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020/Reuters
Coronavirus chronicle

Novartis, US regulators agree to malaria drug trial against Covid-19

Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017/ Reuters
Coronavirus chronicle

Malaria drug is biggest hope against coronavirus: Novartis CEO

A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange (NYSE) in New York, US, July 29, 2019/ Reuters
World

Pfizer, Novartis lead $2 billion spending spree on gene therapy production

Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker
World

Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker

US FDA says some data testing Novartis' $2 million gene therapy was manipulated
Global Economy

US FDA says some data testing Novartis' $2 million gene therapy was manipulated